Aeglea BioTherapeutics · conference-presentation
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides
33 pages · 6 arc beats · 2 loops
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides
Aeglea BioTherapeutics · 2022-02Deck intelligence map
6 Narrative range 9 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem Statement 2 slides 100% 2/2 slides 100% 2/2 slides · 12 hits — 0/2 slides
— 0/2 slides
— 0/2 slides
100% 2/2 slides · 3 hits — 0/2 slides
Key Messages 2 slides 100% 2/2 slides 100% 2/2 slides · 12 hits — 0/2 slides
— 0/2 slides
— 0/2 slides
100% 2/2 slides · 3 hits — 0/2 slides
Patient Medical History 2 slides 100% 2/2 slides 100% 2/2 slides · 9 hits — 0/2 slides
— 0/2 slides
50% 1/2 slides 100% 2/2 slides — 0/2 slides
Diagnostic Methods and Biochemistry Labs 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits — 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides — 0/1 slides
Pegzilarginase Program Overview 1 slides 100% 1/1 slides 100% 1/1 slides · 5 hits — 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Summary and Conclusions 1 slides 100% 1/1 slides 100% 1/1 slides · 3 hits — 0/1 slides
100% 1/1 slides — 0/1 slides
100% 1/1 slides — 0/1 slides